We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Akcea Therapeutics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 98 → 0 (-98)

100% less capital invested

Capital invested by funds: $287M → $0 (-$287M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
–
Holders Change
-98
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$104M
2
BlackRock
BlackRock
New York
-$39.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$24.9M
4
GF
Gabelli Funds
New York
-$10.9M
5
Wells Fargo
Wells Fargo
California
-$8.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
– -$104M -5,716,836 Closed
BlackRock
2
BlackRock
New York
– -$39.9M -2,201,538 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$24.9M -1,372,903 Closed
GF
4
Gabelli Funds
New York
– -$10.9M -599,625 Closed
Wells Fargo
5
Wells Fargo
California
– -$8.13M -447,981 Closed
CS
6
Credit Suisse
Switzerland
– -$7.13M -392,768 Closed
BG
7
Bellevue Group
Switzerland
– -$6.17M -340,264 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$5.75M -317,000 Closed
State Street
9
State Street
Massachusetts
– -$5.59M -308,217 Closed
Renaissance Technologies
10
Renaissance Technologies
New York
– -$4.98M -274,404 Closed
Northern Trust
11
Northern Trust
Illinois
– -$4.6M -253,393 Closed
CS
12
Candriam SCA
Luxembourg
– -$4.43M -244,395 Closed
Citigroup
13
Citigroup
New York
– -$3.99M -220,124 Closed
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
– -$3.97M -219,033 Closed
WIC
15
Water Island Capital
New York
– -$3.96M -218,000 Closed
GI
16
GAMCO Investors
Connecticut
– -$3.87M -213,107 Closed
DAM
17
DLD Asset Management
New York
– -$3.75M -206,864 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$3.55M -195,555 Closed
KC
19
Kellner Capital
New York
– -$3.52M -194,100 Closed
GCIA
20
Gabelli & Co Investment Advisers
New York
– -$2.68M -147,574 Closed
AA
21
ALPS Advisors
Colorado
– -$2.35M -129,589 Closed
Charles Schwab
22
Charles Schwab
California
– -$2.01M -110,837 Closed
Nuveen
23
Nuveen
North Carolina
– -$1.84M -101,322 Closed
Goldman Sachs
24
Goldman Sachs
New York
– -$1.33M -73,522 Closed
Qube Research & Technologies (QRT)
25
Qube Research & Technologies (QRT)
United Kingdom
– -$1.3M -71,689 Closed
1
2 3 4

AKCA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2020, worth a combined $0 — down 100% from $287M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of AKCA and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2020, down from 98 in Q3 2020.
  • Funds reported $0 of Akcea Therapeutics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Akcea Therapeutics Inc positions in Q4 2020 and 98 closed out, a net change of -98 holders.
  • The largest Akcea Therapeutics Inc seller in Q4 2020 was Fidelity Investments, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2020.